Filing metadata

Accession number
0001209191-21-043008
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Jun 24, 2021
Reporting period
Jun 23, 2021
Description
Insider transaction

Explore SEC Filings Hub